T2 Biosystems Inc Price/Book
Cos'è Price/Book di T2 Biosystems Inc?
Price/Book di T2 Biosystems Inc è -0.37
Qual è la definizione di Price/Book?
Il rapporto Price to book rappresenta il rapporto tra il valore delle azioni di una società e il valore contabile per azione.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book di aziende nel Health Care settore su NASDAQ rispetto a T2 Biosystems Inc
Cosa fa T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Aziende con price/book simili a T2 Biosystems Inc
- GVK Power & Infrastructure ha Price/Book di -0.38
- Freedom Foods ha Price/Book di -0.38
- Enlighta ha Price/Book di -0.38
- Intercontinental Gold and Metals ha Price/Book di -0.37
- Just Inc ha Price/Book di -0.37
- ZoomAway Travel ha Price/Book di -0.37
- T2 Biosystems Inc ha Price/Book di -0.37
- ARSS Infrastructure Projects ha Price/Book di -0.37
- Summi () ha Price/Book di -0.37
- AIFarm ha Price/Book di -0.37
- FRX Innovations ha Price/Book di -0.36
- Community Health Systems ha Price/Book di -0.36
- Shanxi Changcheng Microlight Equipment Co ha Price/Book di -0.36